Clinical Trials Directory

Trials / Conditions / Type2 Diabetes Mellitus

Type2 Diabetes Mellitus

112 registered clinical trials studyying Type2 Diabetes Mellitus11 currently recruiting.

StatusTrialSponsorPhase
RecruitingSnapDandCGMinType2Diabetes
NCT07533604
Ramathibodi HospitalN/A
Enrolling By Invitation"Effect of Omega-3 Supplementation as Add on Therapy on Glycemic Control and Lipid Profile in Type2 Diabetes M
NCT07352618
Bangladesh Medical UniversityN/A
Not Yet RecruitingINcreasing the Uptake of DSMES Program and Addressing Social Needs in Low-Income VulneRablE Immigrants
NCT07296211
NYU Langone HealthN/A
Not Yet RecruitingDiet and Progression of CKD in Patients With Type 2 Diabetes Mellitus
NCT07169786
Mariam Emeel Haleem Naseem
CompletedComparative Effectiveness of Tirzepatide Versus Sitagliptin in Individuals at Cardiovascular Risk (TIRZSITA-CV
NCT07203677
Brigham and Women's Hospital
RecruitingClinical Study to Assess the Safety, Efficacy and In-Use Tolerability of Herbal-Based Sugar Support Effervesce
NCT06961019
NovoBliss Research Pvt LtdN/A
Not Yet RecruitingA Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Ad
NCT07044765
AJU Pharm Co., Ltd.Phase 1
Not Yet RecruitingA Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Ad
NCT07034781
AJU Pharm Co., Ltd.Phase 1
CompletedEffects of Marching Exercise With Cognitive Training on Physical, Cognitive Function, and Autonomic Cardiovasc
NCT07330700
Chonticha KaewjohoN/A
CompletedObservational Study on GER in Patients With Simple Obesity
NCT07188571
Jing Ma
Active Not RecruitingEffort During Resistance Training in Type 2 Diabetes
NCT06497842
University of New MexicoN/A
Not Yet RecruitingA Study to Assess Effect of Glucocil® on Metabolic Health in Individuals With Prediabetes and Type 2 Diabetes
NCT06496893
Vedic Lifesciences Pvt. Ltd.N/A
Active Not RecruitingA Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mel
NCT06257966
Beijing Dongfang Biotech Co., Ltd.Phase 3
Not Yet RecruitingEffects of a Health Intervention on Fear of Hypoglycemia
NCT06464900
Yangzhou UniversityN/A
RecruitingEffect of Henagliflozein on Hepatic Fat Content in Patients With T2DM and NAFLD
NCT06449833
Zhujiang HospitalPhase 4
CompletedA Study to Compare the Pharmacokinetics and the Safety Between a Fixed-dose Combination Administration of "BR3
NCT06289933
Boryung Pharmaceutical Co., LtdPhase 1
CompletedBioequivalence Study of Empagliflozin 25 mg Film Coated Tablets of Humanis, Turkey and Jardiance (Empagliflozi
NCT06180109
Humanis Saglık Anonim SirketiPhase 1
RecruitingNephroprotective Effect of Nicorandil in Type 2 Diabetes Mellitus
NCT06430125
Tanta UniversityPhase 3
CompletedPhase 1b/2a Study of GSBR-1290 in Adult Overweight or Obese Healthy Subjects and Subjects With Type 2 Diabetes
NCT05762471
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure TherapeuticsPhase 1 / Phase 2
UnknownAI Health Assistant and Type 2 Diabetes
NCT05539066
Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineN/A
CompletedWeb-based Diabetic Foot Care Training Prepared With the Health Belief Model for Type 2 Diabetes Patients
NCT05395442
Yuzuncu Yil UniversityN/A
UnknownThe Influencing Factors of 12 Week Efficacy of Polyethylene Glycol Losenatide in Type 2 Diabetes Patients
NCT05611684
Nanjing First Hospital, Nanjing Medical UniversityPhase 4
UnknownEffects of Vitamin D Supplementation on SOD,IL-6 and Insulin Resistance in Type 2 Diabetes Mellitus (DM)
NCT05596383
Trisakti UniversityN/A
WithdrawnEfficacy and Safety of Lima Association in the Control of Type II Diabetes Mellitus.
NCT03766750
EMSPhase 3
UnknownHigh Protein Effect on Body Composition and Sarcopenia Markers in Older Patients With Type 2 Diabetes Mellitus
NCT05457088
National and Kapodistrian University of AthensN/A
WithdrawnEmpagliflozin Effect on Glucose Toxicity
NCT03437330
University Hospital TuebingenPhase 4
CompletedThe Effect of Multidomain Dietary Education in Type 2 Diabetic Adults
NCT05892861
National Kaohsiung Normal UniversityN/A
CompletedA Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-383.
NCT04810676
Chong Kun Dang PharmaceuticalPhase 1
UnknownInvestigating Plasma Biomarker Molecules Associated With the Progression of Prediabetes to Overt Type 2 Diabet
NCT04851223
University of Roehampton
CompletedAnti-thrombotic and Glucose Lowering Therapy in Diabetic Patients Undergoing PCI
NCT04481997
Associacao para Investigacao e Desenvolvimento da Faculdade de Medicina - CETERA
CompletedFeasibility of an Online Exercise Community Among Individuals With Type 2 Diabetes
NCT05668442
Mathias Ried-Larsen
CompletedDiabetes Nutrition Education With Glycemic Control
NCT04440319
Andalas UniversityN/A
UnknownThe Metabolic Impact of Bariatric Surgery Compared to Best Diabetic Care on Manitoba's Urban Indigenous Popula
NCT03301545
University of ManitobaN/A
UnknownChanges of Muramyl Dipeptide in Intestinal and Extra-intestinal Diseases
NCT04924686
Zhujiang Hospital
UnknownResponse of Gut Microbiota in Type 2 Diabetes to Hypoglycemic Agents
NCT04287387
Peking Union Medical College HospitalPhase 4
UnknownA Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-396
NCT04246190
Chong Kun Dang PharmaceuticalPhase 1
UnknownA Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Adult Volun
NCT04223895
Chong Kun Dang PharmaceuticalPhase 1
UnknownA Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-375
NCT04221360
Chong Kun Dang PharmaceuticalPhase 1
CompletedMetabolic, Physical Responses To Exercise In Patients With Type 2 Diabetes Mellitus
NCT03682445
Pamukkale UniversityN/A
UnknownScreening, Early Referral and Lifestyle Tailored E_prescription for Cardiovascular Prevention
NCT04082091
Aga Khan University
CompletedClinical Trial for the Investigational Drug (PB-201) in Subjects With Type 2 Diabetes Mellitus
NCT03973515
PegBio Co., Ltd.Phase 1
UnknownQatar Diabetes Mobile Application Trial
NCT03998267
Hamad Medical CorporationN/A
CompletedPharmacokinetics, Safety and Tolerability of CKD-387 10/500mg BE Phase1
NCT04156685
Chong Kun Dang PharmaceuticalPhase 1
CompletedPerformance Evaluation of an Advanced Algorithm With CGM in Adults, Adolescents, and Pediatrics
NCT03966911
Medtronic MiniMed, Inc.N/A
CompletedGuide To Goals: A Novel Care Coordination Tool for Children With Type Two Diabetes (T2D)
NCT03926598
Georgia Institute of Technology
CompletedTolerance & Responsiveness Improvement for Metformin (TRIM)
NCT03670043
West Side Institute for Science and EducationPhase 4
CompletedMil Familias Cohort Establishment: a Study to Understand Determinants of Diabetes and Its Complications Among
NCT03830840
Sansum Diabetes Research Institute
CompletedSTAR Study Investigating Performance and Safety of the Medical Device SiPore15™
NCT03823027
Sigrid Therapeutics ABN/A
CompletedIRAPe, Irisin and IL-34 in Patients With Type 2 Diabetes
NCT04107259
Damanhour University
UnknownPharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 in Healthy Adults
NCT03849261
Chong Kun Dang PharmaceuticalPhase 1
CompletedEffect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
NCT03590626
Medanta, The Medicity, IndiaN/A
CompletedExercise Volume and Beta-cell Function in T2D The DOSE-EX Randomized Trial
NCT03769883
Mathias Ried-LarsenN/A
UnknownThe Progress of Diabetes Mellitus After HMS5552 Treatment in Type 2 Diabetes Mellitus
NCT04091854
Majianhua
Completed"POWER2DM Evaluation Campaign"
NCT03588104
Leiden University Medical CenterN/A
UnknownFinancial Incentives for Low Socioeconomic Diabetic Patients
NCT03506230
Clalit Health ServicesN/A
UnknownDiabetes and Osteopathic Manipulative Medicine (OMM)
NCT03663322
New York Institute of TechnologyN/A
CompletedSmectite Gel and Probiotic for Obesity and Insulin Resistance
NCT04293731
Bogomolets National Medical UniversityN/A
CompletedThe MHERO Study (Michigan's Hypertension, Diabetes, and Obesity Education Research Online)
NCT03729479
University of MichiganPhase 1 / Phase 2
CompletedA Pilot Study to Assess the Safety of Oral Insulin in Patients With Nonalcolholic Steatohepatitis (NASH)
NCT02653300
Oramed, Ltd.Phase 2
CompletedMulticenter Study to Evaluate the Effect of BTI320 on Glycemic Control in Type 2 Diabetes
NCT03655535
Boston TherapeuticsPhase 2
WithdrawnNeujia Anastomosis for Treatment of Obesity and Type II Diabetes
NCT03675074
Neurotronic, Inc.N/A
CompletedInvestigate the Efficacy and Safety of Low-Glu in Patients Newly Diagnosed With Type II Diabetes Mellitus
NCT05343767
Natural Wellness EgyptN/A
CompletedSafety and Efficacy of Bexagliflozin in Subjects With Moderate Hepatic Impairment
NCT03557658
TheracosPhase 1
CompletedEffects of Dapagliflozin+Saxagliptin in Addition to Metformin v/s Saxagliptin or Dapagliflozin in Patients Wit
NCT03714594
University of PisaPhase 2
CompletedFiber Mix and Glycemic Response
NCT03334643
Rutgers, The State University of New JerseyN/A
CompletedOrange Juice And Sugar Intervention Study
NCT03527277
University of California, DavisN/A
CompletedMetabolic Effects of Pulse Consumption on Biomarkers in Adults With Type 2 Diabetes or Met Syn
NCT05145998
Iowa State UniversityN/A
UnknownInfluence of Injection Technique of Premixed Insulin on Glucose Excursion in Type 2 Diabetes Mellitus
NCT03513055
Nanjing First Hospital, Nanjing Medical UniversityN/A
CompletedDietary Interventions on Glycocalyx Dimensions in South Asian Patients With Diabetic Nephropathy.
NCT03889236
Leiden University Medical CenterN/A
UnknownRelation of Epicardial Fat and Diabetic Nephropathy in Egyptian Patients
NCT03470415
Assiut University
Active Not RecruitingBehavioral Chronotype: Impact on Sleep and Metabolism
NCT03647306
University of ChicagoN/A
CompletedHeart Rate During Exercise in Type 2 Diabetes
NCT03917576
Universidad de Los LagosN/A
UnknownA Nurse-led Smartphone-based Self-management Programme for Type 2 Diabetes Patients With Poor Blood Glucose Co
NCT03088475
National University of SingaporeN/A
CompletedComparison of Insulin Tregopil (IN-105) With Insulin Aspart in Type 2 Diabetes Mellitus Patients
NCT03430856
Biocon LimitedPhase 2 / Phase 3
CompletedHigh-fat Overfeeding, Hepatokines and Appetite Regulation
NCT03369145
Loughborough UniversityN/A
UnknownEffects of SGLT2 Inhibition on Myocardial Insulin Sensitivity
NCT03313752
Andrea GiaccariPhase 3
UnknownThe Effectivity and Safety Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus
NCT03239119
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Phase 3
CompletedSafety and Efficacy of Bexagliflozin Compared to Placebo as Add-on Therapy to Metformin in Type 2 Diabetes Sub
NCT03259789
TheracosPhase 3
UnknownTreatment of Type 2 Diabetes With Ketogenic Diet
NCT03652649
Mid-Atlantic Epilepsy and Sleep Center, LLCN/A
WithdrawnEmpowerment, Motivation and Medical Adherence (EMMA).
NCT03008395
Nova Scotia Health AuthorityN/A
CompletedEffects of Neuromuscular Electrical Stimulation on Glucose Variability in Patients With Type 2 Diabetes
NCT03256747
Hospital de Clinicas de Porto AlegreN/A
WithdrawnEffects of Canagliflozin on Intravascular Volume and Hemodynamics
NCT03190798
The University of Texas Health Science Center at San AntonioPhase 4
CompletedMil Familias-Santa Barbara's Operational Pilot to Understand Diabetes in the Latino Community
NCT03736486
Sansum Diabetes Research Institute
CompletedBexagliflozin Drug/Drug Interaction Study With Digoxin
NCT03197324
TheracosPhase 1
CompletedBexagliflozin Drug/Drug Interaction Study With Exenatide Injection
NCT03167411
TheracosPhase 1
CompletedSGLT-2 Inhibitor and Myocardial Perfusion, Function and Metabolism in T2 DM Patients at High Cardiovascular Ri
NCT03151343
Caroline M KistorpPhase 3
CompletedEffect of Evogliptin on Albuminuria in Patients With Type 2 Diabetes and Renal Insufficiency
NCT03667300
Samsung Medical CenterPhase 2
CompletedEffect of Triticale, Mung Bean and Adzuki Bean Intervention on Patients With Type 2 Diabetes
NCT02999867
Peking Union Medical College HospitalN/A
UnknownStudy to Develop a Kinetic Model for FDG and Me4FDG in Kidneys of Type 2 Diabetic Patients
NCT03557138
Medical University of ViennaN/A
UnknownBuilding a Healthy Temple: a Diabetes Self-management Support Program in Hispanic Faith Community Settings
NCT03934593
The University of Texas at San AntonioN/A
CompletedTeneligliptin Versus Linagliptin in Diabetes Mellitus Type Two Patients
NCT03011177
Handok Inc.Phase 4
UnknownFormat of Patient Education for Different Sociodemographic Groups
NCT02961517
University of Leicester
CompletedEffect of Sodium Glucose Co-transporter 2 Inhibitor on Inflammatory Cytokine in Type 2 Diabetes
NCT02964572
Yonsei UniversityN/A
CompletedInteraction of Bexagliflozin With Metformin, Glimepiride and Sitagliptin
NCT02956044
TheracosPhase 1
CompletedMedStar Diabetes Pathway Chart Reviews
NCT03442595
Medstar Health Research Institute
CompletedThe Effects of Short Message Notifications on Middle-Aged Diabetic Patients
NCT04733612
Istanbul UniversityN/A
CompletedFFAR Agonist on Incretins, Insulin, Lipids and Inflammation
NCT03062592
Odense University HospitalN/A
CompletedAdipose Tissue Expandability and Type 2 Diabetes
NCT03155412
Charles University, Czech Republic
CompletedMAD Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PB-119 to Subjects Wi
NCT03072407
PegBio Co., Ltd.Phase 1
CompletedA Phase 2 Study of DS-8500a in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)
NCT02628392
Daiichi Sankyo Co., Ltd.N/A
UnknownMultiple Ascending Dose Study of HM12470 in Type 1 and Type 2 Diabetes Mellitus
NCT03332849
Hanmi Pharmaceutical Company LimitedPhase 1
CompletedStudy of Association of Salivary Adipokines With Prediabetes and Type 2 Diabetes Mellitus
NCT03901248
India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals
CompletedSaxagliptin in Combination With Dapagliflozin - Effects on Islet Cell Function
NCT02304081
Prof. Dr. Thomas ForstPhase 4
CompletedContinuous Multiple Dose PB-119 Injection in Health Volunteers
NCT03062774
PegBio Co., Ltd.Phase 1
Unknown"Preventing Cardiovascular Ischemic Events and Arresting Their Consequences in Type 2 Diabetic Population
NCT02248311
Hospital Universitari Vall d'Hebron Research Institute
CompletedBasal Insulin Strategies Before Surgery
NCT03104738
Ohio State UniversityN/A
CompletedShoulder Corticosteroid Injection in Diabetic Patients
NCT03652480
University of Turin, Italy
CompletedHeart Rate Variability and Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients
NCT02996539
Shi wei, MM
CompletedAlcohol Consumption and Type 2 Diabetes Mellitus Risk in Nonalcoholic Fatty Liver Disease
NCT03847116
Ningbo No. 1 Hospital
CompletedMorbidity in Newly Diagnosed type2 Diabetes in Adults
NCT02002091
University of Algiers
Completedn-3 Fatty Acid Effects in T2DM After Acute High Intensity Exercise
NCT03182712
Federal University of Rio Grande do SulN/A
CompletedBehavioral Change Communication for Physical Activity Among Females With Type2 Diabetes Mellitus
NCT00690326
Thiruvananthapuram Medical CollegeN/A